The case for more frequent screening.
Thermography isn't new. What's new is making it accessible, affordable, and personal.
Our mission
No woman should wait three years for awareness.
In the US, screening mammograms typically start at age 40 and are recommended annually or every other year through at least age 74. Women under 40 with a family history are often advised to begin earlier, sometimes with supplemental MRI.
Roughly 80% of women 50–74 are up to date on mammograms (past 2 years), per 2023 CDC data. For the 40–49 group, it's lower — about 62%. Uninsured women lag well behind: only about 50% screened vs. 72% of those with Medicaid/public insurance, and rural women screen less than urban women.
Evidence-based
Thermographic imaging has a 30-year clinical history. Our AI model is trained on over 2 million scans and validated in peer-reviewed studies.
Privacy-first
Your data is end-to-end encrypted. We will never share your health information with insurers, employers, or data brokers — period.
Accessible by design
At $29.99 per scan, BreastCheck costs less than a monthly gym membership. No clinic. No parking fees. No waiting room.
Sustainably made
Plastic-free packaging. Single-use pads made from biodegradable materials. Carbon-neutral fulfilment since 2023. radiates naturally.
Thermography vs mammogram
Heat speaks before lumps form.
Thermography reads subtle temperature patterns linked to changes in tissue. It complements your mammogram — it doesn't replace it.
- No radiation. Safe to use every six months, without compromise.
- No compression. Comfortable, painless, and private.
- Pattern comparison. Your second scan is more useful than your first.
| What to compare | Davion | Mammogram |
|---|---|---|
| Frequency | Every 3 mo | Every 1–3 yrs |
| Where | Home | Clinic |
| Radiation | None | Low dose |
| Compression | None | Yes |
| Cost per check | $20 | $100–350 |
BreastCheck is a screening companion, not a diagnostic device. Continue routine mammograms as advised by your doctor.
The team
Built by women, for women.
Dr. Rachel Davies
Co-founder & CMO · Oncologist
Amara Patel
Co-founder & CEO
Sophie Lin
Head of AI Research
Kate Murray
Head of Clinical Affairs